With its pioneering approach to heart failure management, Acorai possesses the potential to significantly impact patient care and healthcare systems, making it an appealing prospect for venture capital investment. The company's strategic focus on non-invasive monitoring aligns with the growing demand for technologies that improve patient outcomes while lowering healthcare costs. Additionally, Acorai's strong financial backing from reputable investors underscores its credibility and potential for growth, making it a compelling opportunity for venture capitalists seeking promising ventures in the healthcare sector.
General Information
BounceWatch is an independent company data service, not affiliated with Acorai. To contact Acorai, visit acorai.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Acorai compare?
A PDF of Acorai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Acorai soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Acorai on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Sweden Market
Health Care
About Acorai
Business keywords: MedTech, Cardiology, Heart Failure Management, Non-invasive Monitoring, Medical Device, FDA Breakthrough Device, Clinical Validation, Regulatory Pathway, Commercialization, Intracardiac Pressure Monitoring, Digital Health, Cardiovascular, Clinical Advisors
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | Undisclosed | 1 | 29 May 2024 | |
| Seed Round | $4.50M | 5 | 19 Jan 2024 | |
| Grant | €2.30M | 1 | 08 Nov 2023 | |
| Seed Round | kr10.95M | 3 | 01 Mar 2023 | |
| Non Equity Assistance | Undisclosed | 4 | 24 Nov 2022 | |
| Seed Round | kr14.46M | 2 | 01 Apr 2022 | |
| Pre Seed Round | kr10.06M | 1 | 15 Jun 2021 | |
| Grant | kr5.48M | - |
|
25 May 2021 |
Latest News
View AllAcorai Alternatives & Competitors
View All AlternativesHarness the power of respiratory-based treatment for hypertension and heart failure with innovative...
A cardiac medical device company determined to improve the lives of heart failure patients through C...
Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure
FAQ About Acorai
Source: BounceWatch company record for Acorai, https://bouncewatch.com/company/acorai, updated 29 December 2024. When citing, please name BounceWatch and link this page.